key: cord-0981154-3vxkfq2g authors: Severo Bem Junior, Luiz; da Cunha Ferreira Neto, Otávio; José Araruna Dias, Artêmio; Fechine de Alencar Neto, Joaquim; Felipe Gonçalves de Lima, Luís; Batista Lemos, Nilson; Maia Silva Diniz, Andrey; Moreira Couto, Kaio; Henrique Estrela Gadelha Maia, Jorge; Cristina Veiga Silva, Ana; Rocha Cirne de Azevedo Filho, Hildo title: Decompressive Hemicraniectomy For Acute Ischemic Stroke: A Neurosurgical View In A Pandemic COVID-19 Time Highlights Of Literature date: 2022-01-07 journal: Interdiscip Neurosurg DOI: 10.1016/j.inat.2021.101485 sha: 722dcf02fdefe7b39bdc417fc656026e2ea4e93e doc_id: 981154 cord_uid: 3vxkfq2g The novel coronavirus, SARS-CoV-2, which was identified after the outbreak in Wuhan, China, in December 2019, has kept the whole world in tenterhooks due to its severe life-threatening nature of the infection. The World Health Organization (WHO) declared coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 a pandemic in 2020, an unprecedented challenge, having a high contagious life-threatening condition with unprecedented impacts for worldwide societies and health care systems. Neurologic symptoms related to SARS-CoV-2 have been described recently in the literature, and acute cerebrovascular disease is one of the most serious complications. The occurrence of large-vessel occlusion in young patients with COVID-19 infection has been exceedingly rare. In this article, we describe the profile of patients undergoing decompressive craniectomy for the treatment of intracranial hypertension by stroke associated with COVID-19 published so far. A narrative review of the central issue in focus was designed: decompressive craniectomy in a pandemic time. Coronavirus disease (COVID-19) acute respiratory syndrome caused by the virus SARS-CoV-2, appeared in the city of Wuhan, China, in December 2019. It presents a picture of acute respiratory syndrome in humans, characterized by fever, dry cough, dyspnea and hypoxia, with features of interstitial pneumonia on chest x-ray or computed tomography [1] . As of this writing, the pandemic has affected more than 210 countries, with more than 29 million confirmed cases and more than 2 million deaths [2] [3] [4] [5] . The virus has an affinity for human angiotensin-converting enzyme protein 2 (hACE2), and recent reports suggest that it is not just the lung that the virus can target. Cases of patients with COVID-19 with mild to severe neurological manifestations (anosmia and ageusia) have been reported [3] [4] [5] [6] [7] [8] . Among a wide range of neurological symptoms, acute cerebrovascular disease is one of the most serious complications and affected 5.7% of patients in the study by Mao has not yet been established whether COVID-19 can be considered a risk factor for stroke. The occurrence of large-vessel occlusion in young patients with COVID-19 infection has been exceedingly rare. Likewise, little is known about any specific characteristics of stroke associated with COVID-19. There are limited data on patients with coronavirus disease with acute ischemic stroke and malignant cerebral edema (MCE) [4, 5] . the purpose of this article is to present a review of published cases on this topic, common characteristics, results and summarize some pertinent issues. For the identification of stroke and COVID-19, a systematic review article was conducted with patients who underwent decompressive craniectomy due to ischemic stroke and had reported cases of COVID -19. It was conducted according to the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines ( Figure 1 ). We systematically searched on PubMed database for related published articles from December first, 2019, to February 3 rd , 2021. The following combination of MeSH terms: "COVID-19" AND "stroke" AND "decompressive craniectomy". Moreover, the PubMed tool -"PubMed Advanced Search Builder'', was used to perform a more specific search, using the term "AND" between all descriptors in the Builder tool. Case reports and correspondences were included. Then, articles with a theme that did not deal with decompressive craniectomy in stroke patients with covid-19 were excluded. The research resulted in seven patients. As analyzed variables were utilized the following variables: gender, age, comorbidities, National Institutes of Health Stroke Scale (NIHSS), hours after symptom onset the surgery was performed (surgery timing), and patient outcome, including Glasgow Coma Scale (GCS) and Rankin Scale. From the literature review, it is possible to analyze eight cases of stroke and decompressive craniectomy of patients infected by COVID-19. In the article published by Rascón Ramírez et al., 2020 [9] , are described two patients with massive stroke and COVID-19, but only one of the patients had decompressive craniectomy, therefore, only one of them met the inclusion criteria. It was observed that the average age was 44.6 years, as the most common comorbidities were hypertension (42.8%) and diabetes (85.7%). The prevalence between genders was 57.1% for males and 42.9% for females. In the study Mao et al. found they showed that the most common neurological symptoms in the patients infected by SARS-CoV-2 are dizziness (about 16%), headache (about 13%) and anosmia (about 5%). Futhermore, anothers neurological symptoms are headache, delirium, epileptic seizure and stroke [15, 16] . Significantly high levels of D-dimer and other fibrin degradation products have been increasingly correlated with poor prognosis in patients infected with SARS-CoV-2 [17] . Due to these characteristics, many authors have reported that patients in this phase of disease and with this laboratory profile are in hypercoagulability state, which can also be associated with a worsening in the functioning of noble organs. For Spiezia et al [18] , patients who have COVID-19 and are in this state of hypercoagulability due to hyperfibrinogenemia, which results in a greater formation of fibrin and polymerization, which can predispose to the appearance of thrombi. The cytokine storm consists of one of the main causes of acute respiratory distress syndrome (ARDS) and multiple organ failure, which is an immunological phenomenon, frequently seen in patients infected with SARS-CoV-2. In a study evaluating the outcome of patients with persistent and high levels of inflammatory cytokines, it was concluded that the overproduction of pro-inflammatory cytokines such as tumor necrosis factor (TNF), IL-6 and IL-1B can cause death if high concentrations persist unabated over time [19] [20] [21] . Therefore, even though any studies did deaths pathologized, through the careful analysis of the cases described above and the literature review brought by each one of them, it is possible to infer that there are pathophysiological correlations between the occurrence of stroke and the associated inflammation. The inflammation and stroke are completely linked to the hypercoaulability processes promoted by the covid-19 infection. What is the difference between characteristics in patients with stroke and COVID-19 infection and without COVID-19? Patients with COVID-19 and stroke were younger than patients with stroke without infection and the onset of neurological symptoms started on average 7 days after the respiratory condition [22] [23] [24] [25] . Patients were less likely to have hypertension. There was no significant difference in other cardiovascular risk factors (diabetes mellitus, dyslipidemia, smoking, coronary artery disease and atrial fibrillation). Stroke severity was greater in stroke patients and COVID-19 and had higher mortality. The DHC is a surgical procedure to reduce increased intracranial pressure and brain tissue displacements that occur in the context of space-occupying lesions such as ischemic stroke [26] . The Inclusion Criteria for Stroke : Age 18 to 60 years, clinical deficits suggestive of infarction in the territory of the MCA with an NIHSS score ≥ 16, Decreased level of consciousness to a score ≥1 in NIHSS item 1a ≥ 16, signs in CT brain of a stroke ≥ 50 percent of MCA territory, with or without infarction free additional in the territory of the anterior cerebral artery or ipsilateral posterior, or volume > 145cm3 the weighted DWI, time from onset of symptoms to the start of surgical decompression <48 hours, written informed consent of the patient or legal representative [26, 27] . Regarding neurosurgical management, the guideline states that patients with ≤ 60 years, who neurologically deteriorate, it is reasonable to have DHC with duraplasty in MCA infarction within 48 h of symptoms onset. In older patients, > 60 years, the same approach can be considered [28] [29] [30] [31] . There are limited data on COVID-19 patients with acute ischemic stroke and MCE [32] . It is unknown whether COVID-19 infection should influence surgical eligibility decision, as these patients can develop severe acute respiratory distress syndrome, acute kidney injury, and, if mechanically ventilated, can have high rates of poor outcome [33] . Clinicians should be mindful of the increased risk for early rapid herniation due to both permissive hypercapnia and hypoxia-induced cerebral vasodilation, particularly among patients with acute respiratory distress syndrome. An early prophylactic DHC strategy in otherwise surgically eligible patients may be appropriate due to the lack of a reliable neurological exam due to sedatives and paralytics usage [26, 36] . The ability to deliver timely and efficacious care for the stroke must be balanced with the risk of potential elevated intracranial pressure that happens as a result of "permissive hypercapnia" during the well-established "protective-lung ventilation strategy" [37] . Rescue approaches such as extracorporeal membrane oxygenation (ECMO) coupled with extracorporeal carbon dioxide removal (ECCO2R) may be applied to avoid lung disease worsening and protect the brain from herniation simultaneously instead of the commonly used one in the pre-pandemic period [40] , excessive conversation about matters not related to the procedure performed must be avoided, to minimize the escape of aerosols; use of two pairs of gloves, placed one under the other, to ensure that there is no contamination due to glove breakage and contact with the surgical means or materials [40] . Furthermore, there is a recommendation for handwashing after the procedure is performed, even if there has been no contamination or violation of the gloves [40] . The number of individuals in the surgical environment should be minimized as much as possible, prioritizing the professionals strictly necessary to the procedure. Everyone who enter the operating room should be encouraged to use individual protection and complete sanitation equipment [41] . In addition, it is essential to take extra care when performing aerosol dispersing procedures, which increases the chance of contamination. For this reason, it is essential to use a room with negative pressurization and located further away from other operating rooms [41] . In our cases analyzed, there was anything unusual that they did during the surgical procedure, only the artificial respiration and infection control. The poor prognosis of patients with COVID-19 and stroke is not fully elucidated. Patients with severe infection are more susceptible to developing acute cerebrovascular events than those with less severe infection. The risk factors for the development of severe COVID-19 are the same as the factors for stroke and cardiovascular disease, and these cardiovascular morbidities are likely to result in worse outcomes [32, 33] . The patients with COVID-19 with large territorial infarction can have a good outcome after decompressive craniectomy. This is particularly true in patients who have minimal respiratory involvement or other extracranial organ damage [34] . Although we have limited follow-up data for survivors and neurological recovery, it is reasonable to expect neurological results similar to those shown in previous DHC studies. Another factor that deserves attention in the analysis of factors that predict the worst outcome of patients with COVID-19 and stroke is hypercapnia caused by mechanical ventilation. Permissive hypercapnia, required during protective mechanical ventilation in patients with severe COVID-19, generates an accumulation of CO2, which can lead to a harmful state of cerebral hyperemia. This permissive hypercapnia is difficult to control in patients with COVID-19, as the patient needs to maintain good pulmonary ventilation, although attention is needed for the possible worsening of the neurological condition through this intervention [28, 34] . SARS-CoV-2 and nervous system-neurological manifestations in patients with COVID-19: A systematic review Mechanisms of Host Defense following Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) Pulmonary Infection of Mice Clinical features of patients infected with 2019 novel coronavirus in Wuhan Neurological Insights of COVID-19 Pandemic Neurological complications of coronavirus and COVID-19 Complicaciones neurológicas por coronavirus y COVID-19 Association of Coronavirus Disease (COVID-19) With Large Vessel Occlusion Strokes: A Case-Control Study Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China Neurologic features in severe SARS-CoV-2 infection Travel medicine and infectious disease Supra and infratentorial massive strokes in previously healthy young patients with SARS-CoV-2. The role of neurosurgery Epub ahead of print Common Carotid Artery Occlusion in a Young Patient: Can Large-Vessel Stroke Be the Initial Clinical Manifestation of Coronavirus Disease 2019? World Neurosurg COVID-19 and Decompressive Hemicraniectomy for Acute Ischemic Stroke Coexistence of COVID-19 and acute ischemic stroke report of four cases China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China SARS-CoV-2 and nervous system -Neurological manifestations in patients with COVID-19: a systematic review Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease The role of D-dimer fibrinogen and C-reactive protein as plasma biomarkers in acute ischemic stroke Clinical Characteristics of Coronavirus Disease 2019 in China COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure Cytokine storm and sepsis disease pathogenesis Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights Acute Stroke Care in the Coronavirus Disease Decompressive craniectomy in traumatic brain injury after the DECRA trial. Where do we stand? Role of Decompressive Craniectomy in Ischemic Stroke. Front Neurol Decompressive craniectomy for acute ischemic stroke StatPearls [Internet Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 -Systematic Review, Meta-analysis, and Meta-regression Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel Effects of the open lung concept following ARDSnet ventilation in patients with early ARDS Emergency room neurology in times of COVID-19: malignant ischaemic stroke and SARS-CoV-2 infection Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection Centers for Diseases Control and Prevention Personal Protective Equipment: Questions and Answers Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) We are grateful to the masters of Hospital da Restauração who provided insight and expertise that greatly assisted the research, and actively stimulated the search for answers. The authors have no potential conflicts of interest to disclose. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors declare that data supporting the findings of this study are available within the article. This study is a review, using secondary data, and ethics approval in human research was not required.